Market Overview

Recap: Genesis Healthcare Q3 Earnings



Shares of Genesis Healthcare (NYSE:GEN) moved higher by 4.3% in pre-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were down 311.54% over the past year to ($0.55), which missed the estimate of ($0.36).

Revenue of $938,653,000 decreased by 16.49% year over year, which missed the estimate of $993,970,000.

Looking Ahead

Genesis Healthcare hasn't issued any earnings guidance for the time being.

Genesis Healthcare hasn't issued any revenue guidance for the time being.

Recent Stock Performance

52-week high: $1.86

Company's 52-week low was at $0.40

Price action over last quarter: down 34.56%

Company Overview

Genesis Healthcare Inc is a post-acute care provider in the United States. It focuses on the medical and physical issues facing elderly patients and is provided by the employees of skilled nursing facilities, assisted/senior living communities, integrated and third-party rehabilitation therapy business. The company has three operating segments. The inpatient services segment include the operation of skilled nursing facilities and assisted/senior living facilities; rehabilitation therapy segment services include integrated and third-party rehabilitation and respiratory therapy services; and all other services. The majority of its revenue is generated from its skilled nursing facilities of the inpatient services segment.


Related Articles (GEN)

View Comments and Join the Discussion!

Posted-In: Earnings News